NCT01676714View on ClinicalTrials.gov

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions
Non-Small Cell Lung CancerColorectal Cancer
Interventions
DRUG

Dovitinib

Trial Locations (1)

95817

University of California Comprehensive Cancer Center, Sacramento

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of California, Davis

OTHER

NCT01676714 - Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter